Bank of Montreal’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.5K | Buy |
15,718
+3,881
| +33% | +$19.6K | ﹤0.01% | 2746 |
|
|
2025
Q1 | $62.6K | Buy |
11,837
+252
| +2% | +$1.33K | ﹤0.01% | 2750 |
|
|
2024
Q4 | $78.3K | Buy |
+11,585
| New | +$78.3K | ﹤0.01% | 2700 |
|
|
2024
Q2 | – | Sell |
-10,333
| Closed | -$124K | – | 3791 |
|
|
2024
Q1 | $124K | Buy |
+10,333
| New | +$124K | ﹤0.01% | 2921 |
|
|
2023
Q4 | – | Sell |
-10,810
| Closed | -$93K | – | 3712 |
|
|
2023
Q3 | $93K | Buy |
+10,810
| New | +$93K | ﹤0.01% | 2875 |
|